Characteristics of patients with neovascular age-related macular degeneration who were lost to follow-up and those of patients who continued follow-up for 2 years after initiating anti-VEGF treatment.

Characteristics of patients with neovascular age-related macular degeneration who were lost to follow-up and those of patients who continued follow-up for 2 years after initiating anti-VEGF treatment.

<p>Characteristics of patients with neovascular age-related macular degeneration who were lost to follow-up and those of patients who continued follow-up for 2 years after initiating anti-VEGF treatment.</p>

Saved in:

Bibliographic Details
Main Author:	Takaaki Sugisawa (13417212) (author)
Other Authors:	Fumi Gomi (278082) (author), Yuri Harada (756097) (author), Hiroko Imaizumi (3545441) (author), Shuichiro Aoki (5778473) (author), Akiko Miki (337892) (author), Maya Kishi (15389105) (author), Tomofusa Yamauchi (428670) (author), Daisuke Nagasato (3574904) (author), Yoko Ozawa (418834) (author), Masatoshi Haruta (9532227) (author), Nobuhiro Kato (21526526) (author), Hisashi Matsubara (651891) (author), Tsutomu Yasukawa (6411377) (author), Aki Kato (588812) (author), Hiroto Terasaki (104937) (author), Takao Hirano (13863990) (author), Yasuhiro Iesato (520685) (author), Hiroki Tsujinaka (8783519) (author), Tomoya Murakami (3134658) (author), Yoshinori Mitamura (361411) (author), Makiko Wakuta (14185640) (author), Kazuhiro Kimura (205831) (author), Masahiko Shimura (19832186) (author)
Published:	2025
Subjects:	Medicine Cell Biology Neuroscience Biotechnology Developmental Biology Cancer Science Policy Infectious Diseases related macular degeneration corrected visual acuity prior treatment history 8 %, 13 2 %, respectively ltfu vary depending xlink "> data poor baseline bcva worse baseline best specific factors associated significantly less likely term ltfu rates vegf treatment combined bcva ), anti time since initiation identify factors associated worse bcva 8 %, xlink "> significantly associated identify time 2 years term ltfu initiated treatment factors contributing early ), whereas ltfu ltfu rate risk factor photodynamic therapy patient characteristics neovascular age january 2017 initiating anti initial visit december 2020 control design 80 years 60 years 3 months 19 pandemic
Tags:	Add Tag No Tags, Be the first to tag this record!

Cannot write session to /tmp/vufind_sessions/sess_abg9hqunddfggkr59ktnr3dhrr